08/06/2024
7:00 AM | TFF Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/08/2024
4:41 PM | ROCAMBOLI STEPHEN (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2024
4:42 PM | Mikhak Zamaneh (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2024
4:43 PM | COLEMAN KIRK ALLEN (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2024
4:43 PM | Roberts Brandi (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2024
4:44 PM | MILLS ROBERT S (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2024
4:44 PM | Lee Catherine Chai-zon (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
07/08/2024
4:46 PM | TFF Pharmaceuticals (Issuer)
Weisman Harlan F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2024
4:40 PM | KING THOMAS BRAXTON (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
7:32 PM | TFF Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2024
4:29 PM | TFF Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
3:03 PM | TFF Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/14/2024
3:04 PM | TFF Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
4:13 PM | INTRACOASTAL CAPITAL, LLC (Filed by)
TFF Pharmaceuticals (Subject)
| Form SC 13G | |
05/08/2024
3:26 PM | CARLSON CAPITAL L P (Filed by)
TFF Pharmaceuticals (Subject)
| Form SC 13G/A | |
05/06/2024
11:15 PM | TFF Pharmaceuticals (Filer)
| Form EFFECT | |
05/01/2024
9:54 AM | TFF Pharmaceuticals (Filer)
| Form 424B4 | |
04/29/2024
11:15 PM | TFF Pharmaceuticals (Filer)
| Form EFFECT | |
04/29/2024
6:15 AM | TFF Pharmaceuticals (Filer)
| Form S-1/A | |
04/29/2024
5:06 AM | TFF Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2024
3:32 PM | TFF Pharmaceuticals (Filer)
| Form S-1/A | |
04/22/2024
7:49 PM | Mikhak Zamaneh (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2024
7:49 PM | COLEMAN KIRK ALLEN (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2024
7:50 PM | Roberts Brandi (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2024
7:51 PM | MILLS ROBERT S (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2024
7:52 PM | Lee Catherine Chai-zon (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2024
7:52 PM | Patane Michael A (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2024
7:53 PM | KING THOMAS BRAXTON (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2024
7:47 PM | TFF Pharmaceuticals (Issuer)
Weisman Harlan F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2024
7:48 PM | ROCAMBOLI STEPHEN (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2024
3:24 PM | TFF Pharmaceuticals (Filer)
| Form ARS | |
04/22/2024
3:24 PM | TFF Pharmaceuticals (Filer)
| Form ARS | |
04/22/2024
3:19 PM | TFF Pharmaceuticals (Filer)
| Form DEF 14A | |
04/22/2024
3:20 PM | TFF Pharmaceuticals (Filer)
| Form DEFA14A | |
04/18/2024
4:20 PM | TFF Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
04/08/2024
5:41 AM | TFF Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
03/28/2024
3:05 PM | TFF Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
3:01 PM | TFF Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/22/2024
7:00 AM | TFF Pharmaceuticals (Filer)
| Form 424B5 | |
02/14/2024
5:48 PM | LYTTON LAURENCE W (Filed by)
TFF Pharmaceuticals (Subject)
| Form SC 13G/A | |
12/19/2023
5:07 AM | TFF Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Tesla Execs are Freaking Out (Ad) It’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it.
And Elon Musk has completely restructured Tesla to chase this opportunity.
This is a once-in-a-lifetime opportunity that you don’t want to miss. Click here to get the details. |
12/12/2023
11:15 PM | TFF Pharmaceuticals (Filer)
| Form EFFECT | |
12/08/2023
3:52 PM | TFF Pharmaceuticals (Filer)
| Form S-3/A | |
12/04/2023
4:25 PM | Lee Catherine Chai-zon (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/04/2023
4:25 PM | Patane Michael A (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/04/2023
4:26 PM | TFF Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/04/2023
4:27 PM | Lee Catherine Chai-zon (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2023
4:28 PM | Patane Michael A (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2023
4:29 PM | ROCAMBOLI STEPHEN (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2023
4:30 PM | MILLS ROBERT S (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2023
4:31 PM | Roberts Brandi (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
4:14 PM | TFF Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/21/2023
3:41 PM | TFF Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
